Titles and Roles
- Assistant Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Director, Adult Sickle Cell Anemia Program
- Grady Health System
- Research Program
- Cancer Genetics and Epigenetics
Board certified in medical oncology, hematology and internal medicine, Morgan McLemore, MD, has an active basic research laboratory focusing on myeloid differentiation.
Dr. McLemore is a member of the Cancer Genetics and Epigenetics Research Program at Winship Cancer Institute of Emory University. He is also a member of the American Society of Hematology.
Dr. McLemore obtained his medical degree from the University of Texas Health Science Center San Antonio and completed Internal Medicine training at Barnes Hospital (Washington University) in St Louis. He went on to complete a fellowship in Hematology and Oncology at Washington University in St. Louis. After completing his clinical training, Dr. McLemore pursued research training in the laboratory of Daniel Link studying cytokine receptor signal transduction.
Dr. McLemore's laboratory is interested in understanding the signals that control normal myeloid differentiation and proliferation and how these are perturbed in acute myeloid leukemia. In pursuing this, his group has identified novel protein: protein interactions in acute myeloid leukemia. In particular, the McLemore laboratory has identified unique roles for Wilms Tumor protein in myeloid malignancies and AKT during normal myeloid development.